Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125906041 | 12590604 | 1 | I | 20160721 | 20160725 | 20160725 | EXP | US-ACI HEALTHCARE LIMITED-1055543 | ACI HEALTHCARE | 0.00 | M | Y | 105.21000 | KG | 20160725 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125906041 | 12590604 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | U | 203244 | 600 | MG | TABLET | TID | |||||||
| 125906041 | 12590604 | 2 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | 2 | MG | TABLET | QD | ||||||
| 125906041 | 12590604 | 3 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | 3 | MG | TABLET | QD | ||||||
| 125906041 | 12590604 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | U | 0 | 8 | MG | TABLET | QD | |||||||
| 125906041 | 12590604 | 5 | SS | GABAPENTIN. | GABAPENTIN | 1 | 0 | 3600 | MG | TABLET | QD | ||||||||
| 125906041 | 12590604 | 6 | SS | GABAPENTIN. | GABAPENTIN | 1 | 0 | 1800 | MG | TABLET | QD | ||||||||
| 125906041 | 12590604 | 7 | C | TIZANIDINE HYDROCHLORIDE. | TIZANIDINE HYDROCHLORIDE | 1 | 0 | 1 | MG | ||||||||||
| 125906041 | 12590604 | 8 | C | TIZANIDINE HYDROCHLORIDE. | TIZANIDINE HYDROCHLORIDE | 1 | 0 | 2 | MG | ||||||||||
| 125906041 | 12590604 | 9 | C | TIZANIDINE HYDROCHLORIDE. | TIZANIDINE HYDROCHLORIDE | 1 | 0 | 4 | MG | QID | |||||||||
| 125906041 | 12590604 | 10 | C | TOPIRAMATE. | TOPIRAMATE | 1 | 0 | 50 | MG | BID | |||||||||
| 125906041 | 12590604 | 11 | C | TOPIRAMATE. | TOPIRAMATE | 1 | 0 | 100 | MG | BID | |||||||||
| 125906041 | 12590604 | 12 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | 100 | MG | BID | |||||||||
| 125906041 | 12590604 | 13 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | 300 | MG | QD | |||||||||
| 125906041 | 12590604 | 14 | C | DOXEPIN HYDROCHLORIDE. | DOXEPIN HYDROCHLORIDE | 1 | 0 | 75 | MG | QD | |||||||||
| 125906041 | 12590604 | 15 | C | VRAYLAR | CARIPRAZINE | 1 | 0 | ||||||||||||
| 125906041 | 12590604 | 16 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | 2 | MG | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125906041 | 12590604 | 1 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125906041 | 12590604 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125906041 | 12590604 | Barrett's oesophagus | |
| 125906041 | 12590604 | Corrective lens user | |
| 125906041 | 12590604 | Dry mouth | |
| 125906041 | 12590604 | Erectile dysfunction | |
| 125906041 | 12590604 | Feeling abnormal | |
| 125906041 | 12590604 | Fibromyalgia | |
| 125906041 | 12590604 | Haematemesis | |
| 125906041 | 12590604 | Heart rate increased | |
| 125906041 | 12590604 | Off label use | |
| 125906041 | 12590604 | Panic attack | |
| 125906041 | 12590604 | Small cell lung cancer | |
| 125906041 | 12590604 | Terminal state | |
| 125906041 | 12590604 | Tooth fracture | |
| 125906041 | 12590604 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |